Navigation Links
Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
Date:3/17/2008

for the treatment of breakthrough pain in cancer and non-cancer patients. In December 2007, Alexza entered into an agreement with Endo Pharmaceuticals to jointly develop AZ-003. Endo is responsible for regulatory, pre-clinical and clinical development, and for commercializing the product in North America. Alexza is responsible for the development of the Staccato Electric Multiple Dose device and has the exclusive right to manufacture the product for clinical development and commercial supply.

-- AZ-007 (Staccato zaleplon) is being developed for the treatment of insomnia in patients who have difficulty falling asleep, including patients who awake in the middle of the night and have difficulty falling back asleep. Alexza filed an Investigational New Drug application in December 2007. In March 2008, the Company completed enrollment in a Phase 1 clinical trial that enrolled 40 healthy volunteers at a single site. The purpose of this trial was to assess the safety, tolerability and pharmacokinetic parameters of a single dose of AZ-007. Using a double-blind, randomized trial design, four doses of AZ-007 (ranging from 0.5 to 4 mg) were compared to placebo. The Company expects to report initial results of this trial in the Q2 2008.

Financial Results -- Three and Twelve Months Ended December 31, 2007 and 2006

The net loss for the years ended December 31, 2007 and 2006, as reported in accordance with accounting principles generally accepted in the United States (GAAP), was $45.1 million and $41.8 million, respectively. GAAP R&D expenses were $13.7 million in the fourth quarter of 2007 and $45.6 million for the year ended December 31, 2007, as compared to $10.5 million and $36.5 million in the comparable periods in 2006. GAAP operating expenses were $17.4 million in the fourth quarter of 2007 and $60.5 million for the year ended December 31, 2007, as compared to $13.9 million and $46.5 million for the comparable periods in 2006. The increases resulted from
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... ALISO VIEJO, Calif. , May 22, 2013  Avanir ... company management will present an overview of the company at ... Health Care Conference , Presentation date: Wednesday May 29, ... , Jefferies 2013 Global Healthcare Conference , Presentation ... a.m. E.T. A live ...
(Date:5/22/2013)... 22, 2013  Grifols, a global healthcare company based ... from a study demonstrating that a higher dose of ... levels of the alpha 1 protein in patients ... are considered within the normal range for healthy individuals. ... low levels of the alpha 1 proteinase inhibitor ...
(Date:5/22/2013)... CITY , May 22, 2013 ... today announced it received 510(k) clearance from the ... diagnostic X-ray image processing workstation that combines radio ... one platform.  Varian,s Nexus DRF Digital X-Ray Imaging ... variety of image receptors, including CCD cameras and ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2
... Oct. 5, 2011 Alma Lasers, a global developer, ... devices for aesthetic and medical applications, announced today that ... program in honor of National Breast Cancer Awareness Month. ... breast cancer survivors during the month of October 2011. ...
... 5, 2011 More than 40 million U.S. ... at home" due to the benefits of a subscription-based ... is a service provider that delivers a suite of ... healthcare to also include meals, transportation, and financial solutions.  ...
Cached Medicine Technology:In Honor of National Breast Cancer Awareness Month, Alma Lasers Launches Nationwide Radiation Tattoo Removal Program, Declare Your Freedom 2A New Model of Healthcare is Unveiled, Offering Seniors Control, Independence and Dignity as They Age 2A New Model of Healthcare is Unveiled, Offering Seniors Control, Independence and Dignity as They Age 3
(Date:5/22/2013)... in households where the parents are married are less ... Rice University and the University of Houston. , "Childhood ... country, with nearly one-third of all U.S. children ages ... associate professor of sociology at Rice and director of ... little research has been conducted to explore the impact ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Digital Advertising ... on behalf of its social media management client, ... a year's supply of the all-natural organic deodorant. The ... awareness of the rapidly-growing start-up deodorant company based in ... a contest or sweepstakes on a Facebook page is ...
(Date:5/22/2013)... NJ) John Theurer Cancer Center at Hackensack University Medical ... will bring together leading cancer experts, for presentation and ... therapy and interventional immunology in oncology, on Friday, June ... to bring together some of the nation,s top immunology ... cell therapies in oncology, both in solid and liquid ...
(Date:5/22/2013)... 22, 2013 DiscountFurnaceFilter.com now offers ... ranging from furnace filters, dehumidifiers, fans, aroma diffusers, ... to add Stadler Form's product line to their ... line (fans, aroma diffusers and dehumidifiers) to accentuate ... Fan is the perfect combination of design and ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Garcinia cambogia select ... suppressing appetite and inhibiting the extra fat being stored in ... to reduce calorie intake. This fat burner helps people in ... him away from overeating. Basically it does this by secreting ... mood and keeps them away from emotional overeating. In this ...
Breaking Medicine News(10 mins):Health News:Children of married parents less likely to be obese 2Health News:Children of married parents less likely to be obese 3Health News:Social Media Management Firm, 21Digital, Launches National Facebook Sweepstakes for Client, Primal Pit Paste 2Health News:Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies 2Health News:DiscountFurnaceFilter.com Now Offers Stadler Form Products - Providing Solutions to All Your Summer Needs 2Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2
... Senator Dole introduces Senator Daschle at his confirmation hearing ... Services , WASHINGTON, Jan. 8 Bipartisan Policy Center ... Department of Health and Human Services Secretary, was introduced ... at his confirmation hearing today. The hearing was convened ...
... Children,s Research Hospital have demonstrated a more effective ... that the antibiotics clindamycin and azithromycin, which kill ... effective than a standard first-line treatment with the ... lyse, or burst. , The finding ...
... FRANCISCO, Jan. 8 Medivation, Inc.,(Nasdaq: MDVN ) ... will present at the 27th Annual J.P. Morgan Healthcare,Conference on ... Westin,St. Francis Hotel in San Francisco. , ... its clinical,development programs for Dimebon for Alzheimer,s and Huntington,s diseases ...
... 8 Cephalon, Inc . (Nasdaq: CEPH ... CEO will present at the J.P. Morgan Healthcare Conference, ... CA at approximately 4:00 p.m. Pacific Time (7 p.m. Eastern ... relations section of the company,s website. The webcast will be ...
... Jan. 8 A proposal by the State of ... Home has prompted the 125,000-member American Legion Department of ... 2009, in order to organize and coordinate its members, ... provides more than $50,000 in direct and in-kind support ...
... The National eHealth Collaborative, formerly AHIC Successor, Inc., today ... which Kevin Hutchinson, President and CEO of Prematics, Inc., ... organization,s 2009 Board of Directors. The Collaborative builds ... (AHIC), a federal advisory committee established in 2005, and ...
Cached Medicine News:Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2
0.5mm 1X2 Teeth with 6mm Tying Platform; in Stainless Steel 125...
... Advantage Chair and Stand is one of ... systems available, yet it does not compromise ... the use of durable mechanical components.,The Advantage ... the eyecare professional who demands the very ...
... the first and always the,best refracting ... standard after nearly 80 years. Every Phoroptor ... smooth rotation of the dials. The virtual ... precise, solid click of the control knobs. ...
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
Medicine Products: